BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33119591)

  • 1. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
    Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
    PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
    Shattock AJ; Benedikt C; Bokazhanova A; Đurić P; Petrenko I; Ganina L; Kelly SL; Stuart RM; Kerr CC; Vinichenko T; Zhang S; Hamelmann C; Manova M; Masaki E; Wilson DP; Gray RT
    PLoS One; 2017; 12(2):e0169530. PubMed ID: 28207809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
    Barker C; Dutta A; Klein K
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventions.
    Bautista-Arredondo S; La Hera-Fuentes G; Contreras-Loya D; Kwan A; Van Buren SJ; Amanze OO; Atobatele A; Adeyemi A; Abatta E; Ogungbemi KM; Sosa-Rubí SG
    PLoS One; 2018; 13(9):e0201706. PubMed ID: 30192765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
    Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
    J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
    Benedikt C; Kelly SL; Wilson D; Wilson DP;
    Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal allocation of HIV resources among geographical regions.
    Kedziora DJ; Stuart RM; Pearson J; Latypov A; Dierst-Davies R; Duda M; Avaliani N; Wilson DP; Kerr CC
    BMC Public Health; 2019 Nov; 19(1):1509. PubMed ID: 31718603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the costs and efficiency of HIV testing and treatment services in rural Malawi: implications for future "test and start" strategies.
    Vyas S; Songo J; Guinness L; Dube A; Geis S; Kalua T; Todd J; Renju J; Crampin A; Wringe A
    BMC Health Serv Res; 2020 Aug; 20(1):740. PubMed ID: 32787835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
    Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
    J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.
    Fraser N; Kerr CC; Harouna Z; Alhousseini Z; Cheikh N; Gray R; Shattock A; Wilson DP; Haacker M; Shubber Z; Masaki E; Karamoko D; Görgens M
    J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S213-20. PubMed ID: 25723987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
    Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
    J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One world, one hope: the cost of providing antiretroviral therapy to all nations.
    Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
    AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costing analysis of national HIV treatment and care program in Vietnam.
    Duong AT; Kato M; Bales S; Do NT; Minh Nguyen TT; Thanh Cao TT; Nguyen LT
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):e1-7. PubMed ID: 23846564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
    Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
    Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
    Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
    Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.
    Menzies NA; Berruti AA; Berzon R; Filler S; Ferris R; Ellerbrock TV; Blandford JM
    AIDS; 2011 Sep; 25(14):1753-60. PubMed ID: 21412127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria?
    Aliyu HB; Chuku NN; Kola-Jebutu A; Abubakar Z; Torpey K; Chabikuli ON
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):221-5. PubMed ID: 22820805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
    Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
    PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.